SQZ Biotechnologies Co | Business Contracts

Transition Consulting Agreement between SQZ Biotechnologies Company and Howard Bernstein, dated November 1, 2022 (Filed With SEC on November 9, 2022)

Amended and Restated Investors Rights Agreement, dated as of December 19, 2019, as amended (Filed With SEC on February 9, 2021)

Form of Indemnification Agreement for Directors and Officers (Filed With SEC on October 26, 2020)

Lease between the Registrant and Arsenal Yards Holding LLC, dated December 11, 2018 (Filed With SEC on October 26, 2020)

Amended and Restated Exclusive Patent License Agreement, dated as of December 1, 2015, by and between the Registrant and Massachusetts Institute of Technology (Filed With SEC on October 9, 2020)

Offer Letter between the Registrant and Teri Loxam, dated July 17, 2019 (Filed With SEC on October 9, 2020)

Separation Agreement between SQZ Biotechnologies Company and Howard Bernstein, dated September 2, 2022 (Filed With SEC on November 9, 2022)

Employment Agreement between SQZ Biotechnologies Company and Marshelle Smith Warren, dated May 25, 2022 (Filed With SEC on August 4, 2022)

Employment Agreement between SQZ Biotechnologies Company and Micah Zajic, dated July 7, 2022 (Filed With SEC on July 11, 2022)

Transition Consulting Agreement between the Registrant and Teri Loxam, dated November 11, 2021 (Filed With SEC on March 16, 2022)

Separation Agreement between the Registrant and Teri Loxam, dated November 3, 2021 (Filed With SEC on March 16, 2022)

Employment Agreement between the Registrant and David First, dated October 29, 2020 (Filed With SEC on March 16, 2022)

Employment Agreement between the Registrant and Howard Bernstein, dated October 29, 2020 (Filed With SEC on March 16, 2022)

Amended Non-Employee Director Compensation Program (Filed With SEC on March 16, 2022)

Separation Agreement between Oliver Rosen and SQZ Biotechnologies Company, dated September 2, 2021 (Filed With SEC on November 10, 2021)

Employment Agreement between the Registrant and Micah Zajic, dated October 29, 2020 (Filed With SEC on February 9, 2021)

Employment Agreement between the Registrant and Lawrence Knopf, dated October 29, 2020 (Filed With SEC on February 9, 2021)

Form of Underwriting Agreement (Filed With SEC on February 9, 2021)

Employment Agreement between the Registrant and Oliver Rosen, M.D., dated October 23, 2020 (Filed With SEC on October 26, 2020)

Employment Agreement between the Registrant and Armon Sharei, Ph.D., dated October 23, 2020 (Filed With SEC on October 26, 2020)

Employment Agreement between the Registrant and Teri Loxam, dated October 23, 2020 (Filed With SEC on October 26, 2020)

Form of Underwriting Agreement (Filed With SEC on October 26, 2020)

2020 Employee Stock Purchase Plan (Filed With SEC on October 26, 2020)

Non-Employee Director Compensation Program (Filed With SEC on October 26, 2020)

2020 Incentive Award Plan and form of agreements thereunder (Filed With SEC on October 26, 2020)

2014 Stock Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on October 26, 2020)

Amended and Restated Investors Rights Agreement, dated as of December 19, 2019, as amended (Filed With SEC on October 26, 2020)

License and Collaboration Agreement among Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., effective as of October 5, 2018 (Filed With SEC on October 9, 2020)

Warrant to Purchase Stock, dated October 21, 2015, issued to Silicon Valley Bank (Filed With SEC on October 9, 2020)

2014 Stock Incentive Plan, as amended, and form of agreements thereunder (Filed With SEC on October 9, 2020)

Specimen Common Stock Certificate (Filed With SEC on October 9, 2020)

Accord relating to License and Collaboration Agreement among Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., effective as of November 5, 2019 (Filed With SEC on October 9, 2020)

Offer Letter between the Registrant and Oliver Rosen, M.D., dated October 31, 2018 (Filed With SEC on October 9, 2020)

Amended and Restated Investors Rights Agreement, dated as of December 19, 2019 (Filed With SEC on October 9, 2020)

SQZ Biotechnologies Co (34)